BeStock  

Steris PLC STE

US equityMarket cap rank #788Medical Devices
$255.76 +$1.00 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $255.76 0.00%
Open$257.05
Prev close$254.76
Day range$254.99 – $259.35
Volume823.5K
Market cap$24.84B
P/E (TTM)30.4
Dividend yield1.01%

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$1.59B+8.8% YoY
Operating profit$313.30M+16.9% YoY
Net profit$214.10M+11.2% YoY
Diluted EPS$2.19+12.9% YoY
Free cash flow$212.90M+5.8% YoY
Operating cash flow$289.00M

Revenue, last 8 quarters

$1.4BDec '24$1.5BMar '25$1.4BJun '25$1.5BSep '25$1.5BDec '25$1.6BMar '26$1.5BJun '26$1.6BSep '26

Net profit, last 8 quarters

$173.3MDec '24$146.1MMar '25$178.0MJun '25$192.5MSep '25$194.3MDec '25$220.3MMar '26$201.0MJun '26$214.1MSep '26

Diluted EPS by quarter

1.75Dec '241.48Mar '251.79Jun '251.94Sep '251.96Dec '252.24Mar '262.04Jun '262.19Sep '26

Free cash flow by quarter

$243.6MDec '24$189.9MMar '25$326.4MJun '25$201.3MSep '25$199.5MDec '25$245.2MMar '26$279.6MJun '26$212.9MSep '26

Annual revenue

$3.1BFY21$4.2BFY22$4.5BFY23$5.1BFY24$5.5BFY25$5.9BFY26

Profitability & balance sheet

Gross margin44.6%
Operating margin19.3%
Net margin13.4%
Return on equity11.6%
Return on assets7.8%
Return on invested capital9.4%
Current ratio2.05
Liabilities / assets32.1%
Cash & investments$531.10M
Total debt$2.01B
Net cash (debt)-$1.48B
Free cash flow / sales15.2%

Where the revenue comes from

Quarter 2027/Q2

By business line

  • Healthcare$1.12B 70.7%
  • Applied Sterilization Technologies (AST)$295.60M 18.6%
  • Life sciences$170.60M 10.7%

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Revenue as Reported $1.59B $1.49B $5.94B $1.59B $1.50B
Total Operating Revenue $1.59B $1.49B $5.94B $1.59B $1.50B
Cost of Revenue $877.80M $808.60M $3.31B $891.20M $840.70M
Gross Profit $710.80M $684.20M $2.63B $697.10M $655.50M
Operating Expense $397.50M $398.30M $1.52B $380.60M $381.80M
Selling and Admin Expenses $366.00M $369.70M $1.41B $351.80M $352.30M
Research & Development $31.50M $28.60M $112.90M $28.80M $29.50M
Operating Profit $313.30M $285.90M $1.11B $316.50M $273.70M
Net Non-Operating Interest Income (Expense) -$7.60M -$12.70M -$50.90M -$12.30M -$12.00M
Non-Operating Interest Income $3.60M $3.10M $9.80M $2.80M $2.90M
Non-Operating Interest Expense $11.20M $15.80M $60.70M $15.10M $14.90M
Other Income (Expense) -$17.80M $300,000.00 -$7.60M $300,000.00 -$3.70M
Special Income (Charges) -$19.10M $0.00 -$4.10M $300,000.00 -$400,000.00
-Less:Restructuring and Mergern & Acquisition $19.10M $0.00 $4.10M -$300,000.00 $400,000.00
Other Non-Operating Income (Expenses) $1.30M $300,000.00 -$3.50M $0.00 -$3.30M
Pretax Profit $288.00M $273.50M $1.05B $304.50M $257.80M
Tax $73.90M $72.50M $262.20M $84.20M $63.50M
Net Profit $214.10M $201.00M $785.10M $220.30M $194.30M
Profit from Continuing Operations $214.10M $201.00M $785.10M $220.30M $194.30M
Minority Interests $400,000.00 $900,000.00 $2.80M $100,000.00 $1.50M
Net Income to Parent Company $213.70M $200.10M $782.30M $220.20M $192.80M
Net Income to Common Stockholders $213.70M $200.10M $782.30M $220.20M $192.90M
Basic EPS $2.20 $2.05 $7.97 $2.25 $1.96
Diluted EPS $2.19 $2.04 $7.93 $2.24 $1.96
Dividend Per Share $0.69 $0.63 $2.46 $0.63 $0.63
Net Income from Discontinuous Operations – – $0.00 $0.00 $0.00

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $10.71B $10.74B $10.74B $10.74B $10.59B
Total Current Assets $2.48B $2.45B $2.39B $2.39B $2.29B
Cash and Cash Equivalents & Short-Term Investments $531.10M $482.30M $439.60M $439.60M $423.70M
-Cash and Cash Equivalents $531.10M $482.30M $439.60M $439.60M $423.70M
Receivables $1.01B $1.01B $1.09B $1.09B $990.60M
-Accounts Receivable $1.01B $1.01B $1.09B $1.09B $990.60M
Inventory $737.00M $712.10M $631.80M $631.80M $673.50M
Other Current Assets $205.90M $238.20M $230.40M $230.40M $198.40M
Total Non-Current Assets $8.23B $8.29B $8.34B $8.34B $8.31B
Net PPE $2.34B $2.32B $2.32B $2.32B $2.29B
-Gross PPE $4.40B $4.32B $4.26B $4.26B $4.21B
-Accumulated Depreciation -$2.05B -$2.00B -$1.94B -$1.94B -$1.92B
Goodwill and Other Intangible Assets $5.68B $5.75B $5.81B $5.81B $5.92B
-Goodwill $4.18B $4.19B $4.19B $4.19B $4.23B
-Other Intangible Assets $1.50B $1.56B $1.62B $1.62B $1.69B
Other Non-Current Assets $215.00M $215.10M $211.40M $211.40M $93.60M
Total Liabilities $3.44B $3.51B $3.54B $3.54B $3.42B
Total Current Liabilities $1.21B $1.28B $1.15B $1.15B $922.30M
Payables $389.70M $430.60M $367.40M $367.40M $295.00M
-Accounts Payable $334.20M $344.10M $338.80M $338.80M $285.10M
-Total Tax Payable $55.50M $86.50M $28.60M $28.60M $9.90M
Current Accrued Expenses $56.80M $66.50M $56.20M $56.20M $111.10M
Short-Term Debt and Capital Lease Obligation $280.30M $279.00M $154.70M $154.70M $34.40M
-Current Debt $243.10M $243.40M $118.90M $118.90M –
-Current Capital Lease Obligation $37.20M $35.60M $35.80M $35.80M $34.40M
Current Provisions $16.50M $14.50M $15.00M $15.00M $16.50M
Current Deferred Liabilities $61.80M $61.10M $59.10M $59.10M $58.80M
Other Current Liabilities $245.50M $278.60M $271.50M $271.50M $218.30M
Total Non-Current Liabilities $2.23B $2.23B $2.40B $2.40B $2.50B
Long Term Accounts Payable and Other Payables $200,000.00 $200,000.00 $300,000.00 $300,000.00 $1.90M
Long Term Debt and Capital Lease Obligation $1.77B $1.77B $1.93B $1.93B $2.02B
-Long Term Debt $1.65B $1.65B $1.81B $1.81B $1.90B
-Long Term Capital Lease Obligation $119.00M $115.30M $119.60M $119.60M $120.90M
Non-Current Liabilities $39.70M $39.60M $39.50M $39.50M $38.80M
Non-Current Deferred Liabilities $389.70M $390.80M $390.70M $390.70M $414.50M
Employee Benefits $10.20M $10.30M $10.00M $10.00M $10.30M
Other Non-Current Liabilities $24.90M $25.20M $22.00M $22.00M $16.40M
Total Equity $7.27B $7.22B $7.20B $7.20B $7.17B
Stockholders' Equity $7.26B $7.21B $7.18B $7.18B $7.15B
Capital Stock $4.11B $4.18B $4.28B $4.28B $4.34B
-Common Stock $4.11B $4.18B $4.28B $4.28B $4.34B
Retained Earnings $3.30B $3.15B $3.02B $3.02B $2.86B
Gains/Losses Not Affecting Retained Earnings -$149.30M -$127.30M -$113.10M -$113.10M -$42.70M
Minority Interests $14.40M $14.50M $13.60M $13.60M $13.40M
Other Equity Interests – – -$100,000.00 -$100,000.00 –

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow $289.00M $367.10M $1.34B $335.40M $298.20M
Net cash flow from continuing operations $288.90M $367.20M $1.34B $335.30M $298.20M
Net Income from Continuing Operations $214.10M $201.00M $785.10M $220.30M $194.40M
Depreciation & Depletion & Amortization $125.60M $123.80M $486.50M $123.40M $122.00M
Deferred Tax -$700,000.00 $600,000.00 -$16.90M -$16.70M -$100,000.00
Other Non-Cash Items -$22.80M $11.10M -$5.40M -$17.70M -$1.00M
Change in Working Capital -$63.40M $17.80M $27.10M $13.50M -$36.00M
-Change in Receivables $3.00M $90.00M -$25.10M -$123.50M -$15.50M
-Change in Inventory -$26.30M -$73.30M -$24.00M $38.50M -$1.80M
-Change in Payables and Accrued Expense -$72.30M $9.10M $98.90M $131.20M -$3.20M
-Change in Other Current Assets $32.20M -$8.00M -$22.70M -$32.70M -$15.50M
Net cash flow from investing -$76.10M -$108.50M -$512.50M -$217.20M -$98.50M
Net Cash Flow from Continuing Investing Activities -$76.10M -$108.50M -$512.60M -$217.30M -$98.40M
Net PPE Purchase and Sale -$76.10M -$87.50M -$358.50M -$90.10M -$88.30M
Net Business Purchase and Sale $0.00 -$16.00M -$20.10M $0.00 -$5.10M
Net Investment Purchase and Sale $0.00 -$5.00M -$134.00M -$127.20M -$5.00M
Financing Cash Flow -$163.50M -$213.50M -$568.20M -$97.90M -$98.00M
Net Cash Flow from Continuing Financing Activities -$163.50M -$213.50M -$568.20M -$97.80M -$98.10M
Net Issuance Payments Of Debt $0.00 -$37.80M -$122.00M $37.80M $0.00
Net Common Stock Issuance -$100.40M -$115.50M -$235.50M -$74.30M -$50.10M
Cash Dividends Paid -$67.00M -$61.40M -$241.80M -$61.80M -$61.90M
Proceeds from Stock Option Exercised $4.50M $1.30M $32.90M $600,000.00 $15.40M
Net Other Financing Charges -$600,000.00 -$100,000.00 -$1.80M -$200,000.00 -$1.40M
Ending Cash Balance $531.10M $482.30M $439.60M $439.60M $423.70M
Net Change in Cash $49.40M $45.00M $260.70M $20.30M $101.60M
Beginning Cash Balance $482.30M $439.60M $171.70M $423.70M $319.20M
Effect of Exchange Rate Changes -$600,000.00 -$2.30M $7.20M -$4.40M $2.90M
Free Cash Flow $212.90M $279.60M $972.40M $245.20M $199.50M
Gain/Loss from Continuing Operations – – $3.30M -$300,000.00 $3.20M
Net Other Investing Changes – – $100,000.00 – –

Discussion

No comments yet — be the first to weigh in on STE.

Sign in to join the discussion.

Scroll to Top